Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Moreno

Showing results (611-620 of 642) with videos related to

Pageof 65
Sort By:
Annals of Hematology|May 11, 2026
Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCTVíctor Torrecillas-Mayayo, Aina Oliver-Caldes, Nuria Martínez-Cibrian, et al.
Science Translational Medicine|February 4, 2021
Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 productionYaochun Wang, Yang Yang, Meng Wang, et al.
Gaceta Medica De Mexico|October 20, 2021
Epidemiology of hospitalized patients with COVID-19 in a tertiary care hospitalGuadalupe Maza-De La Torre, Edgardo A Montelongo-Mercado, Héctor F Noyola-Villalobos, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 15, 2025
Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation TrialsDavid F Moreno, Albert Oriol, Javier de la Rubia, et al.
Cancer Immunology Research|June 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is LimitedLuis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol, et al.
Pediatric Transplantation|September 19, 2020
The pediatric solid organ transplant experience with COVID-19: An initial multi-center, multi-organ case seriesMatthew B Goss, N Thao N Galván, Wenly Ruan, et al.
Breast Cancer Research and Treatment|April 1, 2024
First-line therapy with palbociclib in patients with advanced HR<sup>+</sup>/HER2<sup>-</sup> breast cancer: The real-life study PALBOSPAINN Martínez-Jañez, M Bellet Ezquerra, L M Manso Sanchez, et al.
BMC Cancer|December 3, 2022
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) studyL de la Cruz-Merino, M Gion, J Cruz, et al.
Genome Announcements|August 6, 2016
Draft Genome Sequence of Fonsecaea nubica Strain CBS 269.64, Causative Agent of Human ChromoblastomycosisFlávia F Costa, Sybren de Hoog, Roberto T Raittz, et al.
Nutricion Hospitalaria|September 30, 1999
[Artificial nutrition in the home. Annual information 1996.Group NADYA-SENPE]C Gómez Candela, A I de Cos, C Iglesias, et al.
Pageof 65

Showing results (611-620 of 642) with videos related to

Sort By:
Pageof 65
Annals of Hematology|May 11, 2026
Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCTVíctor Torrecillas-Mayayo, Aina Oliver-Caldes, Nuria Martínez-Cibrian, et al.
Science Translational Medicine|February 4, 2021
Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 productionYaochun Wang, Yang Yang, Meng Wang, et al.
Gaceta Medica De Mexico|October 20, 2021
Epidemiology of hospitalized patients with COVID-19 in a tertiary care hospitalGuadalupe Maza-De La Torre, Edgardo A Montelongo-Mercado, Héctor F Noyola-Villalobos, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 15, 2025
Is t(11;14) Always a Standard-Risk Cytogenetic Abnormality? Results From GEM05MENOS65 and GEM2012 PETHEMA/GEM Transplantation TrialsDavid F Moreno, Albert Oriol, Javier de la Rubia, et al.
Cancer Immunology Research|June 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is LimitedLuis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol, et al.
Pediatric Transplantation|September 19, 2020
The pediatric solid organ transplant experience with COVID-19: An initial multi-center, multi-organ case seriesMatthew B Goss, N Thao N Galván, Wenly Ruan, et al.
Breast Cancer Research and Treatment|April 1, 2024
First-line therapy with palbociclib in patients with advanced HR<sup>+</sup>/HER2<sup>-</sup> breast cancer: The real-life study PALBOSPAINN Martínez-Jañez, M Bellet Ezquerra, L M Manso Sanchez, et al.
BMC Cancer|December 3, 2022
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) studyL de la Cruz-Merino, M Gion, J Cruz, et al.
Genome Announcements|August 6, 2016
Draft Genome Sequence of Fonsecaea nubica Strain CBS 269.64, Causative Agent of Human ChromoblastomycosisFlávia F Costa, Sybren de Hoog, Roberto T Raittz, et al.
Nutricion Hospitalaria|September 30, 1999
[Artificial nutrition in the home. Annual information 1996.Group NADYA-SENPE]C Gómez Candela, A I de Cos, C Iglesias, et al.
Pageof 65